Challenges in Pharmacodynamic Studies of Antimicrobial Resistance

Abstract

Get full access to this article

View all access options for this article.

References

Schentag

Meagher

Forrest

. Fluoroquinolone AUIC break points and the link to bacterial killing rates. Part l: in vitro and animal models. Ann Pharmacother 2003; 37: 1287–98. DOI 10.1345/aph.1C199

Hooper

. Mechanisms of fluoroquinolone resistance. Drug Resist Update 1999; 2: 38–55.

Bagel

Hullen

Wiedemann

Heisig

. Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli. Antimicrob Agents Chemother 1999; 43: 868–75.

Ince

Hooper

. Mechanisms and frequency of resistance to gatifloxacin in comparison to AM-1121 and ciprofloxacin in Staphylococcus aureus. Antimicrob Agents Chemother 2001; 45: 2755–64.

Gootz

Zaniewski

Haskell

Kaczmarek

Maurice

. Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and grlA and gyrA mutants of Staphylococcus aureus. Antimicrob Agents Chemother 1999; 43: 1845–55.

Trucksis

Hooper

. Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus. Antimicrob Agents Chemother 1996; 40: 1881–8.

Andersson

Levin

. The biological costs of antibiotic resistance. Curr Opinion Microbiol 1999; 2: 489–93.

Lipsitch

Levin

. The population dynamics of antimicrobial chemotherapy. Antimicrob Agents Chemother 1997; 41: 363–73.

Martinez

Baquero

. Mutation frequencies and antibiotic resistance. Antimicrob Agents Chemother 2000; 44: 1771–7.

10.

Mouton

Dudley

Cars

Derendorf

Drusano

. Standardization of pharmacokinetic/pharmacodynamic (pk/pd) terminology for anti-infective drugs. Int J Antimicrob Agents 2002; 19: 355–8.

11.

Pickerill

Paladino

Schentag

. Comparison of the fluoroquinolones based on pharmacokinetic and pharmacodynamic parameters. Pharmacotherapy 2000; 20: 417–28.

12.

Zhanel

Walters

Laing

Hoben

. In-vitro pharmacodynamic modeling simulating free serum concentrations of fluoroquinolones against multidrug-resistant Streptococcus pneumoniae. J Antimicrob Chemother 2001; 47: 435–40.